RWD319 AN EMPIRICAL STUDY ON THE DISCOUNTING RATE OF PHARMACOECONOMIC EVALUATIONS IN CHINA
Pharmacoeconomic evaluations aim to maximize health outcomes from limited healthcare resources. When the evaluation time horizon exceeds one year, current guidelines recommend discounting future costs and outcomes to present values. Given the dynamic nature of China’s economic development, there is a pressing need to reassess and update the discount rate.
Authors
- Xuan Xia (ORCID: https://orcid.org/0000-0002-0118-7482)
- Xiaoning He (ORCID: https://orcid.org/0000-0001-9080-7219)
- Jing Wu (ORCID: https://orcid.org/0000-0002-7427-1482)
- Chang Su (ORCID: https://orcid.org/0000-0003-4857-2414)
Publication Details
- Journal
- Value in Health Regional Issues
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.vhri.2025.101486
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00